ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code)
Benchmark Index
Inception date
Creation Unit
AUM (KRW)
KB RISE HealthCare Fixed Income Balanced ETF
(253290)
FnGuide HealthCare Mix Index
2016.09.23
200,000
21,400,222,922
Trustee
Market Price per share (KRW)
NAV
Trading Volume (shares)
하나은행
11,830
※ t-1 last price
11,889
77,491
authorized participant, Liquidity provider table
Total Expense Ratio
Distribution Frequency
Year 0.35%
(Designated participating company : 0.001%,
Collective investment : 0.309%,
trust : 0.02%,
General affairs : 0.02%)
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number)
Name
Ticker
Number of shares
Weight(%)
Market price (KRW)
1
KTB03375-3103(26-3)
KR103503GG37
555,555,555
22.78
546,957,777
2
RISE KTB
KR7114100001
4,422
19.56
469,638,510
3
KTB02750-2812(25-10)
KR103501GFC3
333,333,333
13.59
326,167,333
4
KTB02250-2806(25-4)
KR103501GF63
333,333,333
13.53
324,891,999
5
RISE HealthCare
KR7253280002
19,141
11.26
270,270,920
6
SAMSUNG BIOLOGICS
KR7207940008
34
2.03
48,620,000
7
Alteogen
KR7196170005
125
1.92
46,187,500
8
KTB3 F 202609
KR4A65690005
0.44
1.89
45,333,200
9
Celltrion
KR7068270008
261
1.89
45,309,600
10
HLB
KR7028300002
663
1.38
33,216,300
11
Yuhan
KR7000100008
310
1.01
24,242,000
12
ABL Bio
KR7298380007
237
1
24,008,100
13
SCD
KR7000250001
78
0.85
20,514,000
14
LCB
KR7141080002
148
0.83
19,906,000
15
SKBP
KR7326030004
224
0.83
19,868,800
16
SAMSUNG EPIS HOLDINGS
KR70126Z0002
37
0.7
16,779,500
17
HanmiPharm
KR7128940004
35
0.62
14,892,500
18
원화예금
KRD010010001
13,279,429
0.55
13,279,429
19
PharmaResearch
KR7214450009
37
0.46
11,026,000
20
HANALL BIOPHARMA
KR7009420001
197
0.45
10,815,300
21
ST Pharm
KR7237690003
73
0.39
9,271,000
22
L&C BIO
KR7290650001
102
0.34
8,180,400
23
Hugel
KR7145020004
30
0.31
7,530,000
24
CLASSYS
KR7214150005
149
0.29
6,846,550
25
ORUM
KR7475830006
103
0.28
6,602,300
26
SKBS
KR7302440003
148
0.24
5,831,200
27
Lunit
KR7328130000
392
0.22
5,335,120
28
SEEGENE
KR7096530001
179
0.21
5,155,200
29
Celltrionph
KR7068760008
114
0.21
4,936,200
30
Pharmicell
KR7005690003
313
0.19
4,460,250
31
GC Biopharma Corp.
KR7006280002
31
0.17
4,048,600
32
CHA Biotech
KR7085660009
335
0.17
4,046,800
33
HK inno.N
KR7195940002
79
0.14
3,266,650
34
Hanmi Science
KR7008930000
114
0.14
3,431,400
35
DAEWOONG PHARM
KR7069620003
25
0.13
3,027,500
36
CHONGKUNDANG
KR7185750007
44
0.13
3,128,400
37
MedyTox
KR7086900008
31
0.11
2,709,400
38
DongKook Pharm
KR7086450004
132
0.1
2,482,920
39
KLS
KR7102940004
42
0.09
2,058,000
40
JWPHARMA
KR7001060003
75
0.09
2,043,750
41
ILDONG PHARM
KR7249420001
118
0.09
2,244,360
42
ShinpoongPharm
KR7019170000
222
0.08
1,982,460
43
HLBPHARMA
KR7047920004
156
0.08
2,017,080
44
i-SENS
KR7099190001
122
0.08
1,971,520
45
CUREXO
KR7060280005
163
0.07
1,678,900
46
EuBio
KR7206650004
174
0.07
1,659,960
47
DENTIUM
KR7145720009
37
0.07
1,648,350
48
GC Corp.
KR7005250006
121
0.06
1,361,250
49
WONTECH
KR7336570007
241
0.06
1,489,380
50
T&L
KR7340570001
26
0.06
1,458,600
51
Binex
KR7053030003
161
0.05
1,276,730
52
Huons Global
KR7084110006
30
0.03
795,000
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.